Finance

Lists
Q2 2027 earnings • released • Revenue beat +8.39%
See results
4183:TYO
Mitsui Chemicals Inc
Â¥1,815.00
-0.33%
(-6.00) 1D
Nov 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4183...
Open
Â¥1,821
High
Â¥1,832
Low
Â¥1,797
Mkt. cap
692.58B
Avg. vol.
4.80M
Volume
5.06M
Dividend
4.13%
Quarterly dividend
Â¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
7.77
52-wk high
Â¥2,478
52-wk low
Â¥1,475
EPS
Â¥233
Shares outstanding
198.74M
No. of employees
17K
Open
Â¥1,821
High
Â¥1,832
Low
Â¥1,797
Mkt. cap
692.58B
Avg. vol.
4.80M
Volume
5.06M
Dividend
4.13%
Quarterly dividend
Â¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
7.77
52-wk high
Â¥2,478
52-wk low
Â¥1,475
EPS
Â¥233
Shares outstanding
198.74M
No. of employees
17K
News stories
From web sources and news partners
Profile
Mitsui Chemicals is a Japanese chemicals company listed on the Nikkei with business interests in Japan, Europe, China, Southeast Asia and the USA. It is one of the leading chemical companies in Japan and is part of the Mitsui conglomerate. The company mainly deals in performance materials, petrochemicals and basic chemicals and functional polymeric materials. Wikipedia
About Mitsui Chemicals Inc
CEOHashimoto Osamu
Employees17K
FoundedOct 1, 1997
HeadquartersMinato City, Tokyo, Japan
SectorMaterials
IndustryCommodity chemical
Last report
Nov 11, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
519.04B / 478.88B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
405.12B
450.04B
460.05B
519.04B
Cost of goods sold
313.15B
341.50B
343.59B
391.59B
Cost of revenue
313.15B
341.50B
343.59B
391.59B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.68B
79.29B
73.39B
84.08B
Operating expense
70.30B
69.10B
74.97B
89.20B
Total operating expenses
383.45B
410.59B
418.56B
480.79B
Operating income
21.68B
39.45B
41.48B
38.25B
Other non operating income
-
-7.36B
-
-
EBT including unusual items
25.37B
17.08B
47.71B
42.87B
EBT excluding unusual items
25.37B
40.63B
47.71B
42.87B
Income tax expense
7.69B
3.53B
10.45B
8.78B
Effective tax rate
30.31%
-
21.90%
20.48%
Other operating expenses
-2.39B
-10.20B
1.58B
5.12B
Net income
14.74B
11.80B
32.09B
26.73B
Net profit margin
3.64%
-
6.98%
5.15%
Earnings per share
-
-
-
-
Interest and investment income
3.49B
2.28B
2.57B
1.95B
Interest expense
-4.83B
-
-3.29B
-4.41B
Net interest expenses
-1.34B
2.28B
-724.00M
-2.46B
Depreciation and amortization charges
-
-
-
-
EBITDA
47.91B
53.62B
70.16B
68.28B
Gain or loss from assets sale
-2.02B
-10.44B
1.40B
-
Upcoming events
AI content may include mistakes. Learn more
Google apps